Women who received left-sided radiation or endocrine therapy appear to be impacted the most by this trend. 

This trend, however, did not carry over to women with high HDL-C levels. 

Researchers hope their work can help guide future treatments for atherosclerosis and other harmful diseases. 

The study included data from more than 165,000 patients with coronary artery disease (CAD).

The devices have been associated with a risk of breaking during use. 

The FDA first announced the detection of high levels of NDMA, a contaminant associated with cancer, in extended-release metformin products back in May 2020. 

Researchers examined 251 patients who had no prior record or symptoms of cognitive decline or dementia before they were hospitalized for COVID-19.

Researchers reported "significant improvements" in patients after one year. 

The American College of Emergency Physicians called the decision a "slap in the face" to providers during the pandemic.